|
Contact Information: Phone: 540-551-5002 Cell: 609-775-5260 |
|
email: dana@danaethomas,com |
|
This list does not represent all the deals completed in the course of my career but does highlight my experience. |
|
To View or Download |
|
Representative Agreements / Licensing Activities – Business Development* |
|
Dana E Thomas Connecting Business Needs with Marketing Excellence |
Company |
Type of Agreement |
Product or Company |
Year Completed |
|
DuPont |
In-Licensing |
Hamilton - Automated Liquid Handling System (for microtiter plates) |
1986 |
|
DuPont |
In-Licensing |
Sterile Connection Device |
1986 |
|
DuPont |
Marketing |
Patient Tracking Computer System |
1986 |
|
DuPont |
Acquisition |
Biotech Research Laboratories |
1987 |
|
DuPont |
Acquisition |
Baxter Critical Care |
1988 |
|
DuPont |
In-Licensing |
RPR (through Chiron), rIL-2 |
1988 |
|
Sherwood |
Out-Licensing |
Bayer Corp., Glycoslated Hemoglobin Control |
1993 |
|
R&D Tech Transfer |
Licensing |
Univ of MO / Colgate, wound healing compound |
1995 |
|
Neoprobe |
Manufacturing & Supply |
Dr. Karl Thomae GmbH, antibody |
1996 |
|
Neoprobe |
Marketing |
United States Surgical |
1996 |
|
Neoprobe |
Marketing & Distribution |
Global Damon Pharm., Korea, Taiwan, Thailand, Singapore, Malaysia |
1996 |
|
Neoprobe |
Marketing & Distribution |
MDS Nordion |
1997 |
|
Neoprobe |
Marketing & Distribution |
Syncor International, US and select markets |
1997 |
|
Neoprobe |
In-Licensing |
CIS, radiopharmaceutical |
1998 |
|
Neoprobe |
Marketing |
J&J, Ethicon |
1998 |
|
Neoprobe |
Distribution |
Cardinal, Cord Logistics |
1998 |
|
Neoprobe |
Marketing & Distribution |
CEI International, Brazil |
1998 |
|
Neoprobe |
Marketing & Distribution |
Evergreen Enterprises Ltd., China |
1998 |
|
Neoprobe |
Marketing & Distribution |
Century Medical, Japan |
1999 |
|
Neoprobe |
Marketing & Distribution |
MD International, South America, Central America, Caribbean |
1999 |
|
Trek |
Marketing & Distribution |
Savyon Diagnostics, Israel |
2000 |
|
Trek |
License / Acquisition |
BD Biosciences |
2000 |
|
Trek |
Development |
Sandy Springs Technologies |
2000 |
|
Trek |
Manufacturing |
Colorado Med Tech |
2000 |
|
Trek |
Acquisition |
Combact Systems, Israel |
2000 |
|
Trek |
Marketing |
bioMérieux |
2000 |
|
Trek |
Marketing |
Dade |
2000 |
|
BioRad Labs |
Development |
Tecan |
2001 |
|
BioRad Labs |
Development |
Mayo Clinic |
2001 |
|
Trinity Biotech |
Distribution |
Fisher Health Care |
2005 |
|
Trinity Biotech |
Acquisition/Due Diligence |
bioMerieux |
2006 |
|
Trinity Biotech |
In-Licensing |
Meridian Diagnostics |
2006 |
|
Cangen Biotechnologies |
Royalty |
Applied Biosystems/Celera |
2007 |
|
Cangen Biotechnologies |
Royalty |
Roche |
2007 |
|
Cangen Biotechnologies |
Funding |
Mizuho Bank, Mitsubishi |
2007 |
|
|
|
|
|
|
|
|
Deal |
|
Sheet |
|
|